135 related articles for article (PubMed ID: 8381146)
1. Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome. A clinical trial to evaluate efficacy and discomfort associated with infection.
Boudreaux AA; Smith LL; Cosby CD; Bason MM; Tappero JW; Berger TG
J Am Acad Dermatol; 1993 Jan; 28(1):61-5. PubMed ID: 8381146
[TBL] [Abstract][Full Text] [Related]
2. Role of intralesional vinblastine administration in treatment of intraoral Kaposi's sarcoma in AIDS.
Flaitz CM; Nichols CM; Hicks MJ
Eur J Cancer B Oral Oncol; 1995 Jul; 31B(4):280-5. PubMed ID: 7492927
[TBL] [Abstract][Full Text] [Related]
3. Oral Kaposi's sarcoma in acquired immunodeficiency syndrome. Review of management and report of the efficacy of intralesional vinblastine.
Epstein JB; Lozada-Nur F; McLeod WA; Spinelli J
Cancer; 1989 Dec; 64(12):2424-30. PubMed ID: 2819653
[TBL] [Abstract][Full Text] [Related]
4. Caution in the use of local therapies for Kaposi's sarcoma.
Tappero JW; Berger TG
Arch Dermatol; 1993 Jan; 129(1):42. PubMed ID: 8420484
[No Abstract] [Full Text] [Related]
5. [Intralesional vinblastine in the treatment of Kaposi's sarcoma. Presentation of a case].
Gaglioti D; Ficarra G; Nardi P
Minerva Stomatol; 1989 Sep; 38(9):955-7. PubMed ID: 2811811
[TBL] [Abstract][Full Text] [Related]
6. Intralesional vinblastine for treating AIDS-associated Kaposi's sarcoma of the oropharynx and larynx.
Friedman M; Venkatesan TK; Caldarelli DD
Ann Otol Rhinol Laryngol; 1996 Apr; 105(4):272-4. PubMed ID: 8604887
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronidase enhances the therapeutic effect of vinblastine in intralesional treatment of Kaposi's sarcoma. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).
Smith KJ; Skelton HG; Turiansky G; Wagner KF
J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):239-42. PubMed ID: 9039176
[TBL] [Abstract][Full Text] [Related]
8. [Intralesional injection of vinblastine in treatment of laryngeal Kaposi sarcoma associated with AIDS].
Gras R; Moulin G; Giovanni A; Chagnaud C; Triglia JM; Zanaret M
Ann Otolaryngol Chir Cervicofac; 1999 Oct; 116(5):291-4. PubMed ID: 10572593
[TBL] [Abstract][Full Text] [Related]
9. Treatment modalities for intraoral Kaposi's sarcoma: report of case.
Chockley B; Coke JM
Spec Care Dentist; 1991; 11(6):231-3. PubMed ID: 1839938
[TBL] [Abstract][Full Text] [Related]
10. Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome.
Volberding PA; Abrams DI; Conant M; Kaslow K; Vranizan K; Ziegler J
Ann Intern Med; 1985 Sep; 103(3):335-8. PubMed ID: 4026082
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Kaposi's sarcoma in acquired immunodeficiency syndrome with an alternating vincristine-vinblastine regimen.
Kaplan L; Abrams D; Volberding P
Cancer Treat Rep; 1986 Sep; 70(9):1121-2. PubMed ID: 3742492
[TBL] [Abstract][Full Text] [Related]
12. Treatment of oral Kaposi sarcoma with intralesional vinblastine.
Epstein JB
Cancer; 1993 Mar; 71(5):1722-5. PubMed ID: 8448735
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Kaposi's sarcoma with vinblastine.
Klein E; Schwartz RA; Laor Y; Milgrom H; Burgess GH; Holtermann OA
Cancer; 1980 Feb; 45(3):427-31. PubMed ID: 7353196
[TBL] [Abstract][Full Text] [Related]
14. Iontophoresis of vinblastine into normal skin and for treatment of Kaposi's sarcoma in human immunodeficiency virus-positive patients. The Military Medical Consortium for Applied Retroviral Research.
Smith KJ; Konzelman JL; Lombardo FA; Skelton HG; Holland TT; Yeager J; Wagner KF; Oster CN; Chung R
Arch Dermatol; 1992 Oct; 128(10):1365-70. PubMed ID: 1417025
[TBL] [Abstract][Full Text] [Related]
15. Intralesional vinblastine injections for the treatment of oral Kaposi's sarcoma: report of 10 patients with 2-year follow-up.
McCormick SU
J Oral Maxillofac Surg; 1996 May; 54(5):583-7; discussion 588-9. PubMed ID: 8632242
[TBL] [Abstract][Full Text] [Related]
16. Primary intraosseous Kaposi's sarcoma of the maxilla in human immunodeficiency virus infection: review of literature and report of case.
Nichols CM; Flaitz CM; Hicks MJ
J Oral Maxillofac Surg; 1995 Mar; 53(3):325-9. PubMed ID: 7532218
[No Abstract] [Full Text] [Related]
17. Intralesional vinblastine in the treatment of oral Kaposi's sarcoma.
Moyle G; Youle M; Barton S
Br J Clin Pract; 1993; 47(2):79-80. PubMed ID: 8334068
[TBL] [Abstract][Full Text] [Related]
18. Local treatment of AIDS-associated bulky Kaposi's sarcoma in the head and neck region.
Shimomura S; Kikuchi Y; Oka S; Ishitoya J
Auris Nasus Larynx; 2000 Oct; 27(4):335-8. PubMed ID: 10996492
[TBL] [Abstract][Full Text] [Related]
19. Intralesional interferon-alpha and zidovudine in epidemic Kaposi's sarcoma.
Dupuy J; Price M; Lynch G; Bruce S; Schwartz M
J Am Acad Dermatol; 1993 Jun; 28(6):966-72. PubMed ID: 8496462
[TBL] [Abstract][Full Text] [Related]
20. Intralesional vinblastine therapy for Kaposi's sarcoma of the epiglottis.
Tami TA; Sharma PK
Otolaryngol Head Neck Surg; 1995 Sep; 113(3):283-5. PubMed ID: 7675491
[No Abstract] [Full Text] [Related]
[Next] [New Search]
